|
1
|
Yasui W: Future perspectives of gastric
cancer treatment: from bench to bedside. Pathobiology. 78:293–294.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Japanese Gastric Cancer Association.
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yanagihara K, Takigahira M, Tanaka H,
Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y and
Hirohashi S: Development and biological analysis of peritoneal
metastasis mouse models for human scirrhous stomach cancer. Cancer
Sci. 96:323–332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hippo Y, Yashiro M, Ishii M, Taniguchi H,
Tsutsumi S, Hirakawa K, Kodama T and Aburatani H: Differential gene
expression profiles of scirrhous gastric cancer cells with high
metastatic potential to peritoneum or lymph nodes. Cancer Res.
61:889–895. 2001.PubMed/NCBI
|
|
5
|
Jass JR, Sobin LH and Watanabe H: The
World Health Organization’s histologic classification of
gastrointestinal tumors. A commentary on the second edition.
Cancer. 66:2162–2167. 1990.
|
|
6
|
Lockhart DJ, Dong H, Byrne MC, Follettie
MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H
and Brown EL: Expression monitoring by hybridization to
high-density oligonucleotide arrays. Nat Biotechnol. 14:1675–1680.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Velculescu VE, Zhang L, Vogelstein B and
Kinzler KW: Serial analysis of gene expression. Science.
270:484–487. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oue N, Hamai Y, Mitani Y, Matsumura S,
Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W: Gene
expression profile of gastric carcinoma: identification of genes
and tags potentially involved in invasion, metastasis, and
carcinogenesis by serial analysis of gene expression. Cancer Res.
64:2397–2405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitani Y, Oue N, Matsumura S, Yoshida K,
Noguchi T, Ito M, Tanaka S, Kuniyasu H, Kamata N and Yasui W: Reg
IV is a serum biomarker for gastric cancer patients and predicts
response to 5-fluorouracil-based chemotherapy. Oncogene.
26:4383–4393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oue N, Sentani K, Noguchi T, Ohara S,
Sakamoto N, Hayashi T, Anami K, Motoshita J, Ito M, Tanaka S,
Yoshida K and Yasui W: Serum olfactomedin 4 (GW112, hGC-1) in
combination with Reg IV is a highly sensitive biomarker for gastric
cancer patients. Int J Cancer. 125:2383–2392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sentani K, Oue N, Sakamoto N, Arihiro K,
Aoyagi K, Sasaki H and Yasui W: Gene expression profiling with
microarray and SAGE identifies PLUNC as a marker for hepatoid
adenocarcinoma of the stomach. Mod Pathol. 21:464–475. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sentani K, Oue N, Sakamoto N, Anami K,
Naito Y, Aoyagi K, Sasaki H and Yasui W: Upregulation of connexin
30 in intestinal phenotype gastric cancer and its reduction during
tumor progression. Pathobiology. 77:241–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu L, Reader JC, Chen C, Zhao XF, Ha JS,
Lee C, York T, Gojo I, Baer MR and Ning Y: Activation of a novel
palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and
subsets of acute myeloid leukemia. Leukemia. 25:367–371. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kondo T, Oue N, Yoshida K, Mitani Y, Naka
K, Nakayama H and Yasui W: Expression of POT1 is associated with
tumor stage and telomere length in gastric carcinoma. Cancer Res.
64:523–529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yasui W, Ayhan A, Kitadai Y, Nishimura K,
Yokozaki H, Ito H and Tahara E: Increased expression of p34cdc2 and
its kinase activity in human gastric and colonic carcinomas. Int J
Cancer. 53:36–41. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ochiai A, Yasui W and Tahara E:
Growth-promoting effect of gastrin on human gastric carcinoma cell
line TMK-1. Jpn J Cancer Res. 76:1064–1071. 1985.PubMed/NCBI
|
|
17
|
Yanagihara K, Tanaka H, Takigahira M, Ino
Y, Yamaguchi Y, Toge T, Sugano K and Hirohashi S: Establishment of
two cell lines from human gastric scirrhous carcinoma that possess
the potential to metastasize spontaneously in nude mice. Cancer
Sci. 95:575–582. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alley MC, Scudiero DA, Monks A, Hursey ML,
Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd
MR: Feasibility of drug screening with panels of human tumor cell
lines using a microculture tetrazolium assay. Cancer Res.
48:589–601. 1988.PubMed/NCBI
|
|
19
|
Sentani K, Oue N, Naito Y, Sakamoto N,
Anami K, Oo HZ, Uraoka N, Aoyagi K, Sasaki H and Yasui W:
Upregulation of HOXA10 in gastric cancer with the intestinal mucin
phenotype: reduction during tumor progression and favorable
prognosis. Carcinogenesis. 33:1081–1088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohno Y, Kihara A, Sano T and Igarashi Y:
Intracellular localization and tissue-specific distribution of
human and yeast DHHC cysteine-rich domain-containing proteins.
Biochim Biophys Acta. 1761:474–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Linder ME and Deschenes RJ: Model
organisms lead the way to protein palmitoyltransferases. J Cell
Sci. 117:521–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mitchell DA, Vasudevan A, Linder ME and
Deschenes RJ: Protein palmitoylation by a family of DHHC protein
S-acyltransferases. J Lipid Res. 47:1118–1127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matakatsu H and Blair SS: The DHHC
palmitoyltransferase approximated regulates Fat signaling and Dachs
localization and activity. Curr Biol. 18:1390–1395. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dunphy JT and Linder ME: Signalling
functions of protein palmitoylation. Biochim Biophys Acta.
1436:245–261. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Resh MD: Fatty acylation of proteins: new
insights into membrane targeting of myristoylated and palmitoylated
proteins. Biochim Biophys Acta. 1451:1–16. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hynes RO: Integrins: Versatility,
modulation, and signaling in cell adhesion. Cell. 69:11–25. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moissoglu K and Schwartz MA: Integrin
signalling in directed cell migration. Biol Cell. 98:547–555. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang X, Kovalenko OV, Tang W, Claas C,
Stipp CS and Hemler ME: Palmitoylation supports assembly and
function of integrin-tetraspanin complexes. J Cell Biol.
167:1231–1240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo W and Giancotti FG: Integrin
signalling during tumour progression. Nat Rev Mol Cell Biol.
5:816–826. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dormond O and Rüegg C: Regulation of
endothelial cell integrin function and angiogenesis by COX-2, cAMP
and Protein Kinase A. Thromb Haemost. 90:577–585. 2003.PubMed/NCBI
|
|
31
|
Sohail A, Sun Q, Zhao H, Bernardo MM, Cho
JA and Fridman R: MT4-(MMP17) and MT6-MMP (MMP25), a unique set of
membrane-anchored matrix metalloproteinases: properties and
expression in cancer. Cancer Metastasis Rev. 27:289–302. 2008.
View Article : Google Scholar : PubMed/NCBI
|
